HIV/AIDS
Researchers from Italy, the United Kingdom and the United States report details of new studies and findings in the area of HIV/AIDS
Published in Medical Letter on the CDC and FDA, May 24th, 2006
Study 1: Infants with perinatal HIV-1 infection benefit from early combined antiretroviral therapy.
Researchers in Italy conducted a study "to investigate the impact of early versus deferred combined antiretroviral treatment (ART) in asymptomatic or moderately symptomatic [Centers for Disease Control and Prevention (CDC) category N, A, or B] infants with perinatal HIV-1 infection."
Elena Chiappini at the University of Florence and collaborators explained, "A multicenter nationwide case-control study was conducted. Data from 30...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Environmental Health
Lead exposure increases risk of low birth weight in Idaho - HIV/AIDS Epidemiology
Current trends in Rwanda's HIV/AIDS epidemic reviewed - Legionellosis
Monochloramine may reduce Legionella colonization of water systems - Pediatric Vaccine
DTaP and MMR shortages impact timeliness of child vaccination coverage - Pneumococcal Vaccine
Pneumococcal vaccine reduces rate of drug-resistant Streptococcus pneumoniae infections - Adenoviral Vector
Replication properties of human adenovirus in different animal species described - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
